Cellosaurus UM-UC-3 LLWO2F (CVCL_A5WT)
Cell line name | UM-UC-3 LLWO2F |
---|---|
Synonyms | LLWO2F |
Accession | CVCL_A5WT |
Resource Identification Initiative | To cite this cell line use: UM-UC-3 LLWO2F (RRID:CVCL_A5WT) |
Comments | Population: Caucasian. Characteristics: Expresses PPP1CA induced by doxycycline. Transfected with the plasmid 6-HA-PP1alpha-pTEP4m plasmid that express a 6His-HA tagged PP1C1 undert the control of a Teto/CMV promoter. Characteristics: Transfected with the plasmid pUHD172-1neo which contains a rtTA under the control of the CMV promoter. The reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=12914669). Genetic integration: Method=Transfection/transduction; Gene=HGNC; 9281; PPP1CA (Note=With a N-terminal His6-HA tag). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo. Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255. |
Sequence variations |
|
Disease | Bladder carcinoma (NCIt: C4912) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_A5WS (UM-UC-3 LLWO1) |
Sex of cell | Male |
Age at sampling | Age unspecified |
Category | Cancer cell line |
Publications | PubMed=12914669; DOI=10.1186/1475-2867-3-12; PMCID=PMC183861 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_A5WT |
Encyclopedic resources | Wikidata; Q107117258 |
Entry history | |
Entry creation | 20-May-2021 |
Last entry update | 10-Sep-2024 |
Version number | 8 |